Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases ...Middle East

News by : (PR Newswire) -
Round led by Gimv, a Belgian based private equity and venture capital firm Round comes just 1 year after raising €5 million seed funding in February 2022 Company aims to transform the treatment of complement mediated conditions MUNICH, April 17, 2023 /PRNewswire/ -- Complement...

Hence then, the article about complement therapeutics secures 72 million in series a financing to advance novel therapies targeting complement mediated diseases was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار